Science-Based Regulation

The speculation about Henney

WASHINGTON - The balance FDA strikes in its efforts to base regulations on sound science between precaution - avoiding mistakes even if doing so blocks access to potentially valuable therapies - and accepting risks if they are justified by public health benefits will be determined in large measure by the character and priorities of the next FDA commissioner.

In addition, the success of FDA reform legislation and the prescription drug user fee program rely on the efficiency and spirit the agency displays in implementing them, which will also be determined in large measure by the management style and capabilities of the next commissioner.